These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30952578)

  • 1. Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su Q; Qin J; Zhou Y; Ruan H; Chen Z; Chen Z; Li H; Zhou Y; Zhou S; Wang X; Zhou L; Huang M
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):165-171. PubMed ID: 30952578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su QB; Tao YQ; Qin JM; Zhou Y; Zhou S; Li HL; Chen ZJ; Zhou YF; Zhou LM; Wang XD; Huang M
    Pharmazie; 2018 May; 73(5):279-282. PubMed ID: 29724294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic variants in six candidate genes with valproic acid therapy optimization.
    Hung CC; Ho JL; Chang WL; Tai JJ; Hsieh TJ; Hsieh YW; Liou HH
    Pharmacogenomics; 2011 Aug; 12(8):1107-17. PubMed ID: 21806385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
    Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
    Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.
    Sha'ari HM; Haerian BS; Baum L; Saruwatari J; Tan HJ; Rafia MH; Raymond AA; Kwan P; Ishitsu T; Nakagawa K; Lim KS; Mohamed Z
    Pharmacogenomics; 2014 Mar; 15(4):459-66. PubMed ID: 24624913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese.
    Li X; Zhang J; Wu X; Yan H; Zhang Y; He RH; Tang YJ; He YJ; Tan D; Mao XY; Yin JY; Liu ZQ; Zhou HH; Liu J
    Pharmacogenomics; 2016 Dec; 17(18):2007-2014. PubMed ID: 27918244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
    Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
    Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
    Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
    Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy.
    Wang Y; Li Z
    Therapie; 2020; 75(3):261-270. PubMed ID: 31474408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
    Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
    Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
    Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
    Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.